Diasome Pharmaceuticals Company

Diasome Pharmaceuticals is a clinical stage diabetes therapeutics company that designs and develops insulin-based therapies. The company’s products include Oral HVD-I, a targeted oral insulin in a pill or gel cap dose form; HDV-I, an injectable short acting insulin; and HDV-B, an injectable basal long acting insulin. It develops products for patients suffering from Type 1 and Type 2 diabetes. Diasome Pharmaceuticals was founded in 2004 and is based in Conshohocken, Pennsylvania.
Industry: PharmTech
Headquarters: Cleveland, Ohio, United States
Zip: 1-10
Founded Date: 2004-01-01
Employees Number: 1-10
Acquisitions Number: 6
Investors Number: 82994379
Total Funding: $1M to $10M
Estimated Revenue: $1M to $10M
Last Funding Date: Venture - Series Unknown
Last Funding Type: info@diasome.com

Visit Website
Register and Claim Ownership